Polymyositis as a manifestation of chronic graft-versus-host disease

Medicine

Volumn 75, Issue 5, 1996, Pages 279-285

  Parker, Pablo ^a   Chao, Nelson J ^a   Ben Ezra, Johnathan ^e   Slatkin, Neal ^a   Openshaw, Harry ^a   Niland, Joyce C ^b   Linker, Charles A ^d   Greffe, Brian S ^c   Kashyap, Ashwin ^a   Molina, Arturo ^a   Nademanee, Auayporn ^a   O'Donnell, Margaret R ^a   Planas, Ina ^a   Sheibani, Khalil ^f,g   Smith, Eileen P ^a   Snyder, David S ^a   Spielberger, Ricardo ^a   Stein, Anthony S ^a   Stepan, Daniel E ^f   Blume, Karl G ^b   Forman, Stephen J ^a   more..

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g Western Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; DRUG RESPONSE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; POLYMYOSITIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INFANT; MALE; MIDDLE AGED; POLYMYOSITIS; PREDNISONE; RETROSPECTIVE STUDIES;

EID: 10144261266     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199609000-00004     Document Type: Article

References (19)

1. Anderson BA, Young V, Kean WF, Ludwin SK, Galbraith PR, Anastassiades TP. Polymyositts in Chronic graft vs host disease. Arch Neurol 39: 188-90, 1982.
2. Blume KG, Forman SJ, O'Donnell MR, Doroshow JH, Krance RA, Nademanee AP, Snyder DS, Schmidt GM, Fahey JL, Metter GE, Hill LR, Findley DO, Sniecinski IJ. Total body irradiation and high-dose etoposide: A new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood 69: 1015-1020, 1987.
3. Clement LT, Dagg MA, Landay A. Characterization of human lymphocyte subpopulations: Alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from leu 2 suppressor cells. J Clin Immunol 4: 395, 1984.
4. Dalakas MC. Polymyositis, dermatomyositis, and inclusion-body myositis. Review article, medical progress. N Engl J Med 325: 1487-1498, 1991.
5. Engel AG, Arahata K. Mononuclear cells in myopathies: Quantitation of functionally distinct subsets, recognition of antigen-specific cell mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 17: 704-21, 1986.
6. Landay A, Gartland GL, Clement LT. Characterization of a phenotypically distinct subpopulation of leu-2 cells that suppress T-cell proliferative responses. J Immunol 131: 2757, 1993.
7. Lister J, Messner H, Keystone AE, Miller R, Fritzler MJ. Autoantibody analysis of patients with graft-versus-host disease. J Clin Lab Immunol 24: 19-23, 1979.
8. Messner HA, Curtis JE, Minden MM. The combined use of cytosine arabinoside, cyclophosphamide, and total body irradiation as preparative regimen for bone marrow transplantation in patients with AML and CML. Semin Oncol 12: 187-9, 1985.
9. Nelson KR, McQuillen MP. Neurologic complications of graft-versus-host disease. Neurol Clin 6: 389-403, 1988.
10. Pier N, Dubowitz V. Chronic graft versus host disease presenting with polymyositis. Br Med J 286: 2024, 1983.
11. Reyes MG, Noronha P, Thomas W, Heredia R. Myositis of chronic graft versus host disease. Neurology 33: 122-4, 1983.
12. Shank B, Chu F, Dinsmore R, Kapoor N, Kirkpatrick D, Teitelbaum H, Reid An, Bonfiglio P, Simpson L, O'Reilly R. Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants. Int J Radiat Oncol Biol Phys 9: 1607-1611, 1983.
13. Sheibani K, Tubbs RR. Enzyme immunohistochemistry: Technical aspects. Sem Diagn Pathol 1: 35-51, 1984.
14. Spiegel TM, Pearson CM. Polymyositis. In: Isselbacher K, Adams R, Braunwald E, Martin J, Petersdorf R, Wilson J, eds. Harrison's principles of internal medicine. Update 3. New York: McGraw-Hill, pp. 209-222, 1982.
15. Sullivan KM. Graft versus host disease. In: Forman SJ, Blume KG, Thomas ED, eds. Bone marrow transplantation. Boston: Blackwell Scientific, 1994.
16. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED. Chronic graft versus host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 57: 267-76, 1981.
17. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 70: 1382-1388, 1987.
18. Urbano-Marquez A, Estruch R, Grau JM, Granena A, Martin-Ortega E, Palou J, Rozman C. Inflammatory myopathy associated with graft versus host disease. Neurology 36: 1091-1093, 1986.
19. Vogelsang GB, Wagner JE. Graft versus host disease. Hematol Oncol Clin North Am 4: 625-40, 1990.